BioNexus Gene Lab Corp. (BGLC) Statistics & Valuation Metrics - Stocknear

BioNexus Gene Lab Corp.

NASDAQ: BGLC · Real-Time Price · USD
5.04
-0.65 (-11.42%)
At close: Sep 05, 2025, 3:59 PM
5.15
2.18%
After-hours: Sep 05, 2025, 07:50 PM EDT

BioNexus Gene Lab Statistics

Share Statistics

BioNexus Gene Lab has 1.8M shares outstanding. The number of shares has increased by 1% in one year.

1.8M
1%
1%
n/a
1.27M
313,436
15.45%

Short Selling Information

The latest short interest is 54.04K, so 3.01% of the outstanding shares have been sold short.

54.04K
3.01%
3.01%
1

Valuation Ratios

The PE ratio is -3.12 and the forward PE ratio is null. BioNexus Gene Lab's PEG ratio is 0.08.

-3.12
n/a
0.52
n/a
0.6
-2.03
0.08
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for BioNexus Gene Lab.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 3.81, with a Debt / Equity ratio of 0.03.

3.81
3.1
0.03
-0.15
-0.09
-74.42

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$317.02K
$-53.28K
30
0.91
5.92

Taxes

3.49K
-0.22%

Stock Price Statistics

The stock price has increased by 22.93% in the last 52 weeks. The beta is 1.89, so BioNexus Gene Lab's price volatility has been higher than the market average.

1.89
22.93%
5.5
3.71
42.79
2,029,066

Income Statement

In the last 12 months, BioNexus Gene Lab had revenue of 9.51M and earned -1.6M in profits. Earnings per share was -0.9.

9.51M
1.29M
-1.57M
-1.6M
-1.42M
-1.57M
-0.9
Full Income Statement

Balance Sheet

The company has 4.38M in cash and 210.56K in debt, giving a net cash position of 4.17M.

4.38M
210.56K
4.17M
-3.44M
9.42M
4.62M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.23M and capital expenditures -226.99K, giving a free cash flow of -2.46M.

-2.23M
-226.99K
-2.46M
-1.38
Full Cash Flow Statement

Margins

Gross margin is 13.56%, with operating and profit margins of -16.55% and -16.81%.

13.56%
-16.55%
-16.77%
-16.81%
-14.94%
-16.55%
-25.88%

Dividends & Yields

BGLC does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for BGLC.

n/a
n/a
n/a
n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Apr 7, 2025. It was a backward split with a ratio of 1:10.

Apr 7, 2025
backward
1:10

Scores

3.07
2